Spending For Science

I am puzzled at some of John Gibbons's remarks in the article about the Office of Technology Assessment (The Scientist, Jan. 20, 1992, page 11). He seems to think we have large deficits because of the tax cuts of the early 1980s. In fact, the annual federal budget has roughly doubled in the past decade, while inflation has been about 50 percent, and the average salary has increased by about 50 percent. In the last three years alone, the federal budget has increased from a trillion dollars or

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the last three years alone, the federal budget has increased from a trillion dollars or so to the current level of more than $1.4 trillion. Had the federal budget been frozen as recently as 1989, the budget would have been balanced by this year, leaving a $50 billion to $100 billion annual surplus. Spending, not tax cuts, is the source of the deficits.

As far as his remark that the federal government cannot increase science funding because he doesn't know where the money will come from, if even 10 percent of the $400 billion increase of the last three years had been devoted to science, federally funded science would be rolling in money. In fact, that $400 billion (none of which went to the military, by the way) is more than the military budget (about $300 billion), nearly the amount of the savings and loan losses (about $500 billion), ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Karl Stengel

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo